Categories: Agenda

Investors Put a Microscope on Pay Problems

Companies including Altria GroupCVS Health and Intel are the latest to have failed say on pay so far this proxy season, as investors zero in on longtime compensation issues that have been magnified by the coronavirus pandemic.

Indeed, investors are carefully scrutinizing how pay, strategy and performance will align to weather the storm. Shareholders may react to perceived failings on issues such as employee health and safety by voting against pay to send a strong message, sources say.

Additionally, traditional pain points for investors, such as one-time awards and lack of pay-for-performance alignment, are driving negative vote campaigns that have led to weak say-on-pay vote results for some companies this year.

admin

Recent Posts

‘Mission First:’ Military Directors More Likely to Hold CEOs Accountable

Boards have been steadily reinforcing their ranks through the addition of more directors with military…

2 months ago

Boards Consider Politically Connected Directors Under New Administration

Governance Professionals Caution Against Knee-Jerk Reactions to Shifting Political Winds Meta Platforms added Dana White,…

2 months ago

Let It Snow: CEOs with Cozy Pay and Cold Returns

Where CEO pay climbed and performance sank last year Danaher and United Parcel Service were…

3 months ago

How Boards Can Craft a Next-Level AI Strategy for 2025

As artificial intelligence grows more accessible, boards may have no choice but to embrace it…

3 months ago

Director Details: Who’s at the Table in 2024

A look at the demographics and skills of S&P 500 directors. Corporate boards have greater…

3 months ago

Long-Tenured Independent Directors Lower Litigation, Activist Risks

Companies with independent directors who've served on the board for more than 15 years are…

3 months ago